Bone mineral density in patients with endogenous subclinical hyperthyroidism: Is this thyroid status a risk factor for osteoporosis?
Abstract
Summary: OBJECTIVE The aim of the present study was to elucidate whether endogenous subclinical hyperthyroidism due to a solitary autonomously functioning thyroid nodule affects bone metabolism and is a risk factor for osteoporosis. DESIGN In a cross‐sectional study measurements of bone mineral density were performed in premenopausal and post‐menopausal women. Patients were categorized into non‐toxic nodular goitre (n= 32), subclinical hyperthyroid (n= 37) and toxic solitary autonomous thyroid nodule (n= 22) subgroups and the results were compared with those of sex and age‐matched control reference population (n= 68). MEASUREMENTS Lumbar spine and femoral neck bone mineral densities were measured by dual energy X‐ray absorptiometry. Single‐photon absorptiometry was applied to the measurement of bone mineral content in the midshaft of the radius. RESULTS In the non‐toxic nodular goitre group, bone densities for all the scanned sites did not differ from the sex and age‐matched reference population. At the L2–4 scanning site a significant decrease in the bone mineral density could be observed only in the toxic nodular goitre group and this decrease was more marked in the postmenopausal (P<0 001) than in the premenopausal females (P < 0 05). At the femoral neck and midshaft radius the mean densitometric values were slightly, but significantly, lower only in the post‐menopausal subclinical hyperthyroid group compared with the reference population (P < 0 01). The bone mineral density of the femoral neck, as well as the bone mineral content of the midshaft radius, was significantly decreased in both the premenopausal and post‐menopausal patients with a toxic solitary nodule. CONCLUSION This study indicates that the bone mineral density of the lumbar spine, femoral neck and the midshaft of the radius are not significantly decreased in premenopausal patients with endogenous subclinical hyperthyroidism resulting from a solitary autonomously functioning thyroid nodule. Conversely, findings hint at the possibility that long‐lasting endogenous subclinical hyperthyroidism may be a contributing factor to the development of osteoporosis in some post‐menopausal women, mostly at sites where cortical bone preponderates.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Cites
Ross, D., Neer, R., Ridgway, E., & Daniels, G. (1987) · American Journal of Medicine · doi:10.1016/0002-9343(87)90219-1 · Cited by 294 · see citing works
Long-term L-thyroxine therapy is associated with decreased hip bone density in premenopausal women.
Paul, T. L., Kerrigan, J., Kelly, A., Braverman, L., & Baran, D. (1988) · Journal of the American Medical Association (JAMA) · doi:10.1001/jama.1988.03720210027023 · Cited by 241 · see citing works
Diamond, T. H., Nery, L., & Hales, I. B. (1991) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem-72-6-1184 · Cited by 225 · see citing works
Long-term thyroxine treatment and bone mineral density.
Franklyn, J., Betteridge, J., Daykin, J., Oates, G., Parle, J., Heath, D., Sheppard, M., Holder, R., & Lilley, J. (1992) · The Lancet · doi:10.1016/0140-6736(92)92423-d · Cited by 216 · see citing works
Accelerated Bone Loss in Hypothyroid Patients Overtreated with L-Thyroxine
Stall, G. M., Harris, S., Sokoll, L. J., & Dawson-Hughes, B. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-4-265 · Cited by 203 · see citing works
OSTEOPOROSIS AND FRACTURES FOLLOWING THYROTOXICOSIS
Fraser, S. A., Smith, D. A., Anderson, J., & Wilson, G. M. (1971) · The Lancet · doi:10.1016/s0140-6736(71)91383-3 · Cited by 159 · see citing works
Lukert, B. P., HIGGINS, J. C., & Stoskopf, M. M. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-5-1056 · Cited by 154 · see citing works
Effect of Hyperthyroidism and Its Treatment on Bone Mineral Content
Toh, S. H. (1985) · Archives of Internal Medicine · doi:10.1001/archinte.1985.00360050147025 · Cited by 153 · see citing works
Harvey, R., McHardy, K. C., REID, I. W., Paterson, F., Bewsher, P. D., Duncan, A., & Robins, S. P. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-6-1189 · Cited by 150 · see citing works
Bone loss in hypothyroidism with hormone replacement. A histomorphometric study
Coindre, J. M. (1986) · Archives of Internal Medicine · doi:10.1001/archinte.146.1.48 · Cited by 149 · see citing works
BONE MINERAL DENSITY AND THYROID HORMONE THERAPY
Ribot, C., Trémollières, F., Pouilles, J., & Louvet, J. (1990) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1990.tb00477.x · Cited by 147 · see citing works
Krølner, B. K., Jørgensen, J., & Nielsen, S. P. (1983) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1983.tb02873.x · Cited by 145 · see citing works
Skeletal integrity in premenopausal and postmenopausal women receiving long-term L-thyroxine therapy
Greenspan, S. L., Greenspan, F. S., Resnick, N. M., Block, J. E., Friedlander, A. L., & Genant, H. K. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90066-7 · Cited by 143 · see citing works
Mineral and Bone Metabolism in Thyroid Disease: A Review
Auwerx, J. H., & Bouillon, R. (1986) · QJM · doi:10.1093/oxfordjournals.qjmed.a068031 · Cited by 113 · see citing works
Lee, M., Kim, S. Y., Lee, M. C., Cho, B. Y., Lee, H. K., Koh, C., & Min, H. K. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-3-766 · Cited by 111 · see citing works
Sex- and age-related changes in bone and serum osteocalcin
Vanderschueren, D., Gevers, G., Raymaekers, G., Devos, P., & Dequeker, J. (1990) · Calcified Tissue International · doi:10.1007/bf02555041 · Cited by 104 · see citing works
Taelman, P., Kaufman, J.-M., Janssens, X., Vandecauter, H., & Vermeulen, A. (1990) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1990.tb00471.x · Cited by 100 · see citing works
Lehmke, J., Bogner, U., Felsenberg, D., Peters, H., & Schleusener, H. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02254.x · Cited by 84 · see citing works
Serum Bone Gla Protein: A Marker of BOne Turnover in Hyperthyroidism*
Garrel, D. R., Delmas, P. D., Malaval, L., & TOURNIAIRE, J. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-5-1052 · Cited by 76 · see citing works
Bone Mineral Density in Premenopausal Women Receiving Long-term Physiological Doses of Levothyroxine
Kung, A. W., & Pun, K. K. (1991) · JAMA · doi:10.1001/jama.1991.03460200068037 · Cited by 69 · see citing works
Hyperthyroidism and calcium metabolism
Smith, D. A., Fraser, S. A., & Wilson, G. M. (1973) · Clinics in Endocrinology and Metabolism · doi:10.1016/s0300-595x(73)80047-7 · Cited by 65 · see citing works
Editorial: Thyroid Hormones and Bone Mass
Baran, D. T., & Braverman, L. E. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-6-1182 · Cited by 56 · see citing works
Faber, J. O., Perrild, H., & Johansen, J. S. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-1-49 · Cited by 50 · see citing works
Effect of hyperthyroidism and its treatment on bone mineral content
Toh, S. H. (1985) · Archives of Internal Medicine · doi:10.1001/archinte.145.5.883 · Cited by 40 · see citing works
Serum osteocalcin in patients taking L-thyroxine who have subclinical hyperthyroidism.
Ross, D. S., Ardisson, L., Nussbaum, S. R., & Meskell, M. J. (1991) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem-72-2-507 · Cited by 38 · see citing works
Gam, A. N., JENSEN, G. F., Hasselström, K., Olsen, M., & Nielsen, K. (1991) · Journal of Endocrinological Investigation · doi:10.1007/bf03346838 · Cited by 36 · see citing works
Krakauer, J. C. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.152.2.360 · Cited by 29 · see citing works
Osteocalcin Levels in Patients with Hyper- and Hypothyroidism
Martinez, M., Herranz, L., de Pedro, C., & Pallardo, L. F. (1986) · Hormone and Metabolic Research · doi:10.1055/s-2007-1012275 · Cited by 28 · see citing works
OSTEOPOROSIS IN THYROTOXICOSIS
Ikkos, D., Katsichtis, P., Ntalles, K., et al. (1971) · The Lancet · doi:10.1016/s0140-6736(71)91323-7 · Cited by 17 · see citing works
Severe Postmenopausal Osteoporosis and Thyroid Hormones
Lakatos, P. L. (1986) · Archives of Internal Medicine · doi:10.1001/archinte.1986.00360210257046 · Cited by 8 · see citing works
[Mean value of bone mineral content in Hungary measured by dual-photon absorptiometry].
Szathmári, M., Szũcs, J., Krasznai, I., et al. (1991) · PubMed · Cited by 2 · see citing works
Self-citationSevere postmenopausal osteoporosis and thyroid hormones
Lakatos, P. L. (1986) · Archives of Internal Medicine · doi:10.1001/archinte.146.9.1859a · Cited by 2 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Subclinical Thyroid Disease: Scientific Review and Guidelines for Diagnosis and Management
Surks, M. I., Ortiz, E., Daniels, G. H., Sawin, C. T., Col, N. F., Cobin, R. H., Franklyn, J. A., Hershman, J. M., Burman, K. D., Denke, M. A., et al. (2004) · JAMA · doi:10.1001/jama.291.2.228 · Cited by 1,800 · see citing works
The Clinical Significance of Subclinical Thyroid Dysfunction
Biondi, B., & Cooper, D. S. (2008) · Endocrine Reviews · doi:10.1210/er.2006-0043 · Cited by 1,418 · see citing works
Cooper, D. S., & Biondi, B. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60276-6 · Cited by 1,039 · see citing works
Biondi, B., Bartalena, L., Cooper, D. S., Hegedüs, L., Laurberg, P., & Kahaly, G. J. (2015) · European Thyroid Journal · doi:10.1159/000438750 · Cited by 323 · see citing works
Screening for Thyroid Disease: An Update
Helfand, M., & Redfern, C. C. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-2-199807150-00020 · Cited by 304 · see citing works
Hyperthyroidism, Bone Mineral, and Fracture Risk—A Meta-Analysis
Vestergaard, P., & Mosekilde, L. (2003) · Thyroid · doi:10.1089/105072503322238854 · Cited by 306 · see citing works
Thyroid Hormone Diseases and Osteoporosis
Delitala, A. P., Scuteri, A., & Doria, C. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9041034 · Cited by 220 · see citing works
Subclinical hyperthyroidism: clinical features and treatment options
Biondi, B., Palmieri, E. A., Klain, M., Schlumberger, M., Filetti, S., & Lombardi, G. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01809 · Cited by 217 · see citing works
Vadiveloo, T., Donnan, P. T., Cochrane, L., & Leese, G. P. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2693 · Cited by 186 · see citing works
Faber, Jensen, Petersen, Nygaard, Hegedüs, & Siersbæk‐Nielsen (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00427.x · Cited by 156 · see citing works
The skeletal consequences of thyrotoxicosis
Nicholls, J. J., Brassill, M. J., Williams, G. R., & Bassett, J. H. D. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0059 · Cited by 138 · see citing works
Bone metabolism during anti‐thyroid drug treatment of endogenous subclinical hyperthyroidism
Mudde, A. H., Houben, A. J. H. M., & Kruseman, A. C. N. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02571.x · Cited by 135 · see citing works
Low normal TSH levels are associated with low bone mineral density in healthy postmenopausal women
Kim, D. J., Khang, Y. H., Koh, J., Shong, Y. K., & Kim, G. S. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02422.x · Cited by 103 · see citing works
Haemodynamic changes following treatment of subclinical and overt hyperthyroidism
Faber, J., Wiinberg, N., Schifter, S., & Mehlsen, J. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1450391 · Cited by 104 · see citing works
Subclinical hypothyroidism and hyperthyroidism. I. Prevalence and clinical relevance
Wiersinga, W. (1995) · The Netherlands Journal of Medicine · doi:10.1016/0300-2977(94)00089-r · Cited by 88 · see citing works
Approach to the Patient with Subclinical Hyperthyroidism
Cooper, D. S. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2472 · Cited by 83 · see citing works
Thyroid dysfunction in the elderly
Boelaert, K. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.30 · Cited by 84 · see citing works
GÜRLEK, A., & GEDIK, O. (1999) · Thyroid · doi:10.1089/thy.1999.9.539 · Cited by 72 · see citing works
Tauchmanovà, L., Nuzzo, V., Del Puente, A., Fonderico, F., Esposito-Del Puente, A., Padulla, S., Rossi, A., Bifulco, G., Lupoli, G., & Lombardi, G. (2004) · Maturitas · doi:10.1016/j.maturitas.2004.02.017 · Cited by 66 · see citing works
Papi, G., Pearce, E. N., Braverman, L. E., Betterle, C., & Roti, E. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.01.004 · Cited by 39 · see citing works
Ugur‐Altun, B., Altun, A., Arikan, E., Guldiken, S., & Tugrul, A. (2003) · Endocrine Research · doi:10.1081/erc-120026945 · Cited by 22 · see citing works
Hong, A. R., & Kang, H.-C. (2023) · Endocrinology and Metabolism · doi:10.3803/enm.2023.1701 · Cited by 15 · see citing works
- Authors
- Földes, J., Tarján, G., Szathmari, M., Varga, F., Krasznai, I., & Horvath, C.
- Affiliations
- Semmelweis University (HU)
- Corresponding author
- Földes, J.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 1993-11
- Volume
- 39
- Issue
- 5
- Pages
- 521-527
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2056889736
- Cited by
- 170
- References
- 32
- Citations by year
- 2025: 2 · 2024: 2 · 2023: 2 · 2022: 3 · 2020: 6 · 2019: 5 · 2018: 2 · 2017: 6 · 2016: 1 · 2015: 6 · 2014: 7 · 2013: 5 · 2012: 14
- FWCI
- 5.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Keywords
- subclinical hyperthyroidism, bone mineral density, osteoporosis, autonomously functioning thyroid nodules, toxic nodular goiter, postmenopausal women, lumbar spine, femoral neck, bone metabolism, cortical bone
- MeSH terms
- Adult, Aged, Cross-Sectional Studies, Female, Femur Neck, Goiter, Nodular, Humans, Hyperthyroidism, Menopause, Middle Aged, Osteoporosis, Risk Factors, Spine, Thyrotropin, Thyroxine, Triiodothyronine, Bone Density, Osteocalcin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review